Left running head: MELTZER et al Right running head: FIBRINOLYSIS AND RISK OF MYOCARDIAL INFARCTION Scientific section designation: CLINICAL TRIALS AND OBSERVATIONS Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men
نویسندگان
چکیده
Mirjam E. Meltzer, Carine J.M. Doggen, Philip G. de Groot, Frits R. Rosendaal, MD, and Ton Lisman Department of Clinical Chemistry and Hematology, University Medical Center Utrecht; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden; 3 Department of Health Technology and Services Research, School for Management and Governance, University of Twente, Enschede; Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden; 6 Surgical Research Laboratory, Department of Surgery, University Medical Center Groningen, University of Groningen, the Netherlands
منابع مشابه
Right running head: FIBRINOLYSIS AND RISK OF VENOUS THROMBOSIS Scientific section designation: CLINICAL TRIALS AND OBSERVATIONS Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
Department of Clinical Chemistry and Hematology, University Medical Center Utrecht; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden; Surgical Research Laboratory, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen; 4 Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam; 5 Department...
متن کاملAntithrombotic therapy to support primary PCI.
The goals of the initial management of ST-segment elevation myocardial infarction include swift restoration of flow within the occluded coronary artery, prevention of early reinfarction, and avoidance of complications of reperfusion therapy.1,2 The selection of the reperfusion strategy, either the preferred percutaneous coronary intervention (PCI) or fibrinolysis, is usually driven by instituti...
متن کاملSevere hypoglycemia predicts major adverse outcomes in diabetic patients undergoing glycemic control regimes
Vascular diseases are the major causes of morbidity and mortality in patients with diabetes mellitus. Better glycemic control reduces microvascular and macrovascular complications in patients with diabetes mellitus. The two large clinical trials of glycemic control in patients with type 1 and type 2 diabetes mellitus, namely the Diabetes Control and Complications Trial (DCCT) and UK Prospective...
متن کاملLow molecular weight heparin: a bridge over troubled water.
adjunct to fibrinolysis (with streptokinase only) validate continued interest in pursuing better thrombin inhibitors. Low molecular weight, active site thrombin inhibitors, (argatroban and melogatran) are currently approved (for HIT) or are in late stage clinical trials. In addition, new parenteral agents which block the coagulation cascade upstream of thrombin, by targeting Factor VII/tissue f...
متن کاملThe metabolic syndrome: more than the sum of its parts?
The prevalence of obesity has risen dramatically in the United States.1 This has led to a marked increase in the metabolic syndrome (MetSyn), a clustering of atherosclerotic cardiovascular disease risk factors characterized by visceral adiposity, insulin resistance, low HDL cholesterol (HDL-C), and a systemic proinflammatory state.2 In the United States, the MetSyn affects roughly 25% of adults...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2010